Corcept Therapeutics (CORT) Net Margin (QoQ) (2012 - 2026)

Corcept Therapeutics (CORT) Net Margin (QoQ) (2012 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Corcept Therapeutics 9.56 Bn 9.22 Bn 162.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -3,075.00
Dec 31, 2025 250.00
Sep 30, 2025 -848.00
Jun 30, 2025 490.00
Mar 31, 2025 -380.00
Dec 31, 2024 -887.00
Sep 30, 2024 414.00
Jun 30, 2024 270.00
Mar 31, 2024 -426.00
Dec 31, 2023 -222.00
Sep 30, 2023 198.00
Jun 30, 2023 828.00
Mar 31, 2023 -108.00
Dec 31, 2022 -1,792.00
Sep 30, 2022 746.00
Jun 30, 2022 217.00
Mar 31, 2022 -810.00
Dec 31, 2021 74.00
Sep 30, 2021 274.00
Jun 30, 2021 -58.00